WBC
ENTA icon

Westpac Banking Corp’s Enanta Pharmaceuticals ENTA Stock Holding History

Westpac Banking Corp’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-11,580
Closed -$382K – 875
2015
Q4 		$382K Hold
11,580
– – ﹤0.01% 733
2015
Q3 		$419K Buy
11,580
+7,400
+177% +$318K ﹤0.01% 678
2015
Q2 		$188K Sell
4,180
-400
-9% -$15.6K ﹤0.01% 665
2015
Q1 		$140K Buy
+4,580
New +$178K ﹤0.01% 910

Other funds holding ENTA

ACM
Apex Capital Management Dayton, Ohio $4.54B AUM 1.74% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Westpac Banking Corp's ENTA Position: Q1 2016 in Review

Westpac Banking Corp sold out of Enanta Pharmaceuticals (ENTA) in Q1 2016, closing a stake of 11,580 shares — an estimated $382K sold.

Westpac Banking Corp first reported a position in ENTA in Q1 2015 and held it in 4 quarters. The position peaked at $419K in Q3 2015. 152 funds tracked by Wall St. Rank hold ENTA as of Q1 2016.

  • Westpac Banking Corp reported no remaining Enanta Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Westpac Banking Corp sold 11,580 Enanta Pharmaceuticals shares in Q1 2016, an estimated $382K.
  • Westpac Banking Corp first reported a position in Enanta Pharmaceuticals in Q1 2015 and held it in 4 quarters.
  • Westpac Banking Corp's Enanta Pharmaceuticals position peaked at $419K in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2016.

Based on Westpac Banking Corp's 13F filing for Q1 2016, filed 13 May 2016.